SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on Capricors 24-month HOPE-3 open-label extension data presented at the World Muscle Society congress; traders are highlighting delayed-start results they view as evidence that deramiocel slows upper-limb decline. Bulls see the data as support for the pending FDA review, while others question how much open-label results can resolve the agencys concerns about the trials statistical analysis.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns upcoming fiscal fourth-quarter report is driving attention, with traders focused on whether tight DRAM and NAND supply, HBM demand and pricing can support a strong outlook. Many expect a beat and continued AI-driven demand, while others warn that high expectations and the memory markets cyclical nature could prompt a sell-the-news reaction or renewed doubts about how long the boom can last.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings 737 MAX software glitch and the FAAs resulting delay to MAX 10 certification are driving discussion, with traders debating whether the issue is a manageable fix or another setback to certification, deliveries, and confidence in Boeing. Many bullish traders call the selloff excessive, while others remain wary of the companys recurring quality and execution problems.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desks prolonged selloff and fresh multiyear lows are fueling concern over slowing growth, weak advertising demand, and competition from Amazon and other platforms. Traders debate whether the decline reflects a damaged business or an oversold opportunity, while many criticize management and point to the companys cash position as a reason for optimism.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods summit and product updatesespecially planned 24/7 stock trading, longer options hours, and agentic trading toolsare drawing attention, alongside September trading-volume figures and analyst upgrades. Traders are enthusiastic about the platform expansion but frustrated that the stock has struggled to hold rallies and break resistance.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Uncertainty over federal cannabis rescheduling is driving attention, especially a procedural pause in the DEA hearing after opponents sought to add a GAO report on gaps in drug-scheduling procedures, delaying the expected administrative law judge recommendation. Traders disagree on the impact: some fear the delay could prolong or threaten Schedule III reform, while others view it as a temporary procedural issue and a buying opportunity.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, reflecting stronger demand for its cancer therapies, is driving a sharp rally and renewed analyst optimism. Traders are also focused on future pipeline data, while debating whether short covering is amplifying the move and whether profit-taking or dilution could weigh on shares.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to include VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage pricing, together with Rocket Mortgages plan to prefer VantageScore for eligible loans, has triggered a sharp selloff as traders reassess FICOs mortgage-market share and pricing power. The debate is whether competition materially weakens FICOs moat or whether the decline overstates the threat given its established role; some traders are looking for a rebound while others expect further pressure.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieves addition to the S&P Total Market and S&P Completion indices drew attention, with traders welcoming the inclusion and discussing potential index-related buying. The broader conversation remains focused on federal cannabis rescheduling: some see the pending Schedule III process as a tailwind, while others are frustrated by delays and uncertainty around the judges recommendation.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths SPAC merger and Nasdaq transition are the main focus, alongside its planned XRP treasury of roughly 473 million tokens. Traders are treating XRPN as an equity proxy for XRP and debating the mergers timing, potential share backing and warrant leverage, while noting sharp moves and trading halts; views on the risk and valuation differ.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why AppFolio (APPF) Fell More Than Broader Market

In the closing of the recent trading day, AppFolio (APPF) stood at $204.43, denoting a -2.66% move from the preceding trading day.

Is AppFolio (APPF) a Buy as Wall Street Analysts Look Optimistic?

Based on the average brokerage recommendation (ABR), AppFolio (APPF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

AppFolio (APPF) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, AppFolio (APPF) closed at $214.85, marking a -2.22% move from the previous day.

AppFolio (APPF) is an Incredible Growth Stock: 3 Reasons Why 

AppFolio (APPF) is well positioned to outperform the market, as it exhibits above-average growth in financials.

AppFolio (APPF) Just Overtook the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

AppFolio (APPF) Beats Stock Market Upswing: What Investors Need to Know

AppFolio (APPF) closed the most recent trading day at $208.48, moving +1.32% from the previous trading session.

Here's Why AppFolio (APPF) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

AppFolio CEO William Trigg Sells 2,057 Shares

AppFolio CEO William Trigg Sells 2,057 Shares...

AppFolio (APPF) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the closing of the recent trading day, AppFolio (APPF) stood at $214.28, denoting a -4.16% move from the preceding trading day.

Brokers Suggest Investing in AppFolio (APPF): Read This Before Placing a Bet

According to the average brokerage recommendation (ABR), one should invest in AppFolio (APPF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

AppFolio, Inc., provides industry-specific cloud-based business software solutions, services, and data analytics for the real estate industry. The firm offers AppFolio Property Manager, a property management solution designed to address the operational and business requirements of property management companies and their business ecosystems, and AppFolio Investment Management, a cloud-based software solution for real estate investment managers of various sizes that provides tools and services designed to streamline their real estate investment management businesses. It also provides services that are designed to enhance, automate, and streamline processes and workflows for property management businesses, such as artificial intelligence leasing assistant, tenant screening, electronic payment, utility management, maintenance contact center, tenant debt collection, and mailing services. The company was founded by Brian Donahoo, Klaus Schauser and Jonathan Walker in 2006 and is headquartered in Santa Barbara, CA.

Appfolio Inc - Ordinary Shares - Class A

Acadia, AppFolio, AKA Brands Among 7 Publicly Listed Firms Charged By SEC Over Whistleblower Protection Violation

Equity

Neutral Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Current Price	$195.82
Prev Close	$197.91
Open	$194.41
Dividend Yield	0.00%
50-Day Moving Average	$203.85
Beta	0.84
Avg. Volume	410,846.55
PE Ratio	45.12

52-Week High	$283.14
52-Week Low	$142.56
Market Capitalization	$7.01B
EPS (Annual)	$3.88
Price to Book	13.32
Revenue Per Employee	$558,649.82

Feed

News

Sentiment

Earnings

Fundamentals

Info

APPF Fundamentals